Orexo AB, a leading pharmaceutical company headquartered in Sweden, focuses on developing innovative treatments for addiction and pain management. Founded in 1995, Orexo has established a strong presence in Europe and North America, with a commitment to addressing unmet medical needs through advanced drug delivery technologies. The company’s core products, including Zubsolv, a sublingual film for opioid dependence, exemplify its unique approach to patient care. Orexo's dedication to research and development has positioned it as a key player in the pharmaceutical industry, with notable achievements in improving treatment outcomes for patients struggling with addiction. With a robust pipeline and a focus on sustainable growth, Orexo continues to make significant strides in enhancing the quality of life for individuals facing complex health challenges.
How does Orexo's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Orexo's score of 49 is higher than 82% of the industry. This can give you a sense of how well the company is doing compared to its peers.
In 2023, Orexo reported total carbon emissions of approximately 1,660,000 kg CO2e, a reduction from about 1,845,000 kg CO2e in 2022. The emissions breakdown for 2023 includes Scope 1 emissions of about 273,000 kg CO2e, Scope 2 emissions of approximately 73,000 kg CO2e, and significant Scope 3 emissions totalling around 1,314,000 kg CO2e. The company has not disclosed specific reduction targets or initiatives under the Science Based Targets initiative (SBTi) or other climate pledges. However, Orexo's commitment to reducing its carbon footprint is evident in the year-on-year decrease in total emissions. The company continues to focus on sustainability practices, although detailed reduction strategies have not been specified. Overall, Orexo's emissions data reflects a proactive approach to climate commitments, aligning with industry standards for transparency and accountability in carbon management.
Access structured emissions data, company-specific emission factors, and source documents
2022 | 2023 | |
---|---|---|
Scope 1 | 284,000 | 000,000 |
Scope 2 | 73,000 | 00,000 |
Scope 3 | 1,488,000 | 0,000,000 |
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Orexo is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.